| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/05/2006 | CA2565437A1 Factor xa inhibitors |
| 01/04/2006 | EP1611119A1 Pi-3 kinase inhibitor prodrugs |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | EP1611089A2 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer's disease |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1409455B1 Prostaglandin analogues-as ep4 receptor agonists |
| 01/04/2006 | EP1408030B1 Novel aliphatic compound, method of synthesis, and method of utilization |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1339677B1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 01/04/2006 | EP1173172B1 Synergistic effects of amlodipine and the hydroxylated metabolite of atorvastatin |
| 01/04/2006 | CN1717411A Phosphorescence compound and electro field light emitting device having the same |
| 01/04/2006 | CN1717390A Piperazine and piperidine derivatives for treatment of neurological diseases |
| 01/04/2006 | CN1717388A Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation |
| 01/04/2006 | CN1715270A Uv decomposable molecules and a photopatternable monomolecular film formed therefrom |
| 01/04/2006 | CN1715269A Cyanopyrrolidine derivatives |
| 01/04/2006 | CN1234661C Method for purifying raw melt of at least one monomer by crystallization |
| 01/03/2006 | US6982339 Production of N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines |
| 01/03/2006 | US6982337 catalytic condensation of N-(2-hydroxyethyl)-2-pyrrolidone (HEP) in the presence of added water; by-product inhibition of N-ethyl-2-pyrrolidone (NEP) |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | CA2247451C Carboxylic acid derivatives having fused rings as retinoic acid receptor agonist |
| 01/03/2006 | CA2156289C Drug composition containing nucleic acid copolymer |
| 12/29/2005 | WO2005123686A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 12/29/2005 | WO2005123671A1 Pyrrole derivative |
| 12/29/2005 | WO2005123670A2 Crystalline form of a substituted pyrrolidine compound |
| 12/29/2005 | WO2005123632A1 Method for producing alkenes by the elimination of water from alcohols, using alkylphosphonic acid anhydrides |
| 12/29/2005 | WO2005123067A1 Peptidomimetic inhibitors of retroviral proteases and their use as antivirals |
| 12/29/2005 | WO2004106295A3 Substituted piperodines and pyrrolidines as calcium sensing receptor modulators and method |
| 12/29/2005 | US20050288496 Derived from 2-aryl-3-alkoxycarbonyl-5-pyrrolinones and 2-aryl-5-pyrrolinones by reaction with diamines or diazo compounds |
| 12/29/2005 | US20050288495 Mono- and bis-hydrazone pigments |
| 12/29/2005 | US20050288494 Derived from 2-aryl-3-alkoxycarbonyl-5-pyrrolinones and 2-aryl-5-pyrrolinones by reaction with diamines or diazo compounds |
| 12/29/2005 | US20050288358 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288352 Lactam fermentation products, e.g., pyrrolooxetanediones or pyrrolothietanediones especially containing a cyclohexane or cyclohexane ring, used as antimicrobial, anticancer or antiinflammatory agents; treating drug resistant cancer |
| 12/29/2005 | US20050288342 For therapy of pain |
| 12/29/2005 | US20050288338 Amido compounds and their use as pharmaceuticals |
| 12/29/2005 | US20050288271 Arylsulfonamides and uses related thereto |
| 12/29/2005 | US20050288228 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 12/29/2005 | US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars |
| 12/29/2005 | CA2569729A1 Peptidomimetic inhibitors of retroviral proteases and their use as antivirals |
| 12/29/2005 | CA2568394A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 12/28/2005 | EP1610176A2 UV decomposable molecules and a photopatternable monomolecular film formed therefrom |
| 12/28/2005 | EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/28/2005 | EP1609785A1 C-glycoside derivatives and salts thereof |
| 12/28/2005 | EP1608646A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 12/28/2005 | EP1608619A1 Muscarinic agonists |
| 12/28/2005 | EP1608618A1 Process for the synthesis of amorphous atorvastatin calcium |
| 12/28/2005 | EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 12/28/2005 | EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases |
| 12/28/2005 | EP1265867B1 Malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 12/28/2005 | EP1031563B1 Sulfonyl derivatives |
| 12/28/2005 | EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma |
| 12/28/2005 | CN1714070A Vitamin d receptor modulators |
| 12/28/2005 | CN1712397A Production of N-vinyl-pryyolidone |
| 12/28/2005 | CN1712396A Gas-phase production of N-hydroxyethyl-pyrrolidone |
| 12/27/2005 | US6979685 Drug mixture comprising 2-(4-Morpholinyl)-1-(2-naphthalenethoxy)cyclopentane; arrhythmia, diseases of central nervous system, convulsions, epileptic spasms, depression, anxiety, schizophrenia, Parkinson's disease, respiratory disorders |
| 12/27/2005 | CA2428271C Cyanopyrrolidine derivatives as inhibitors of dpp-iv |
| 12/27/2005 | CA2305463C Aminobutanoic acid derivatives |
| 12/27/2005 | CA2206799C Small molecule inhibitors of rotamase enzyme activity |
| 12/22/2005 | WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 12/22/2005 | WO2005121123A1 Compounds as cor5 antagonists |
| 12/22/2005 | WO2005121117A1 Processes for production of optically active compounds |
| 12/22/2005 | WO2005121083A1 Process for the preparation of n-akyl-pyrrolidones |
| 12/22/2005 | WO2005121082A1 Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation |
| 12/22/2005 | WO2005121081A1 Method for producing acetamidopyrrolidine derivative and intermediate compound thereof |
| 12/22/2005 | WO2005121080A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 12/22/2005 | WO2005120494A1 1-`(3r)-amino-4-(2-fluoro-phenyl)-butyl !-pyrrolidine-(2r)-carboxilic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus |
| 12/22/2005 | WO2005113558A3 Simple stereocontrolled synthesis of salinosporamide a |
| 12/22/2005 | US20050282972 contacting a olefin monomer (isobutylene) with an initiator( 2-chloro-2,4,4,-trimethylpentane) in the presence of a Lewis acid and solvent under suitable quasiliving polymerization reaction conditions, contacting quasiliving carbocationically terminated polymer with a pyrrole compound as quenching agent |
| 12/22/2005 | US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR |
| 12/22/2005 | US20050282886 Lactam tachykinin receptor antagonists |
| 12/22/2005 | US20050282885 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 12/22/2005 | US20050282884 N-aryl-carbamic acid ester-derived and valeric acid ester-derived cross-linkers and conjugates, and methods for their synthesis and use |
| 12/22/2005 | US20050282875 Pyrrolidinium derivatives |
| 12/22/2005 | US20050282872 Novel thyroid receptor ligands and method II |
| 12/22/2005 | US20050282868 Substituted anthranilamides for controlling invertebrate pests |
| 12/22/2005 | US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 12/22/2005 | DE102004024772A1 Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid |
| 12/22/2005 | CA2576236A1 1-`(3r)-amino-4-(2-fluoro-phenyl)-butyl !-pyrrolidine-(2r)-carboxilic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus |
| 12/22/2005 | CA2570179A1 Method for producing acetamidopyrrolidine derivative and intermediate compound thereof |
| 12/22/2005 | CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 12/22/2005 | CA2568700A1 Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation |
| 12/22/2005 | CA2567513A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 12/21/2005 | EP1607386A1 Lipid metabolism improving agent |
| 12/21/2005 | EP1607090A1 Asimadoline for the treatment of irritable bowel syndrome |
| 12/21/2005 | EP1606623A2 Labelling agents for mass spectrometry comprising tertiary amines |
| 12/21/2005 | EP1606284A1 Compositions useful as protein kinase inhibitors |
| 12/21/2005 | EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 12/21/2005 | EP1606254A1 2,4,6-phenyl substituted cyclic ketoenols |
| 12/21/2005 | EP1606253A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of leuvlinic acid esters with nitro compounds |
| 12/21/2005 | EP1606252A2 Production of n-(methyl-aryl)-2-lactam, n-(methyl cycloaklyl)-2-lactam and n-alkyl-2-lactam by reductive amination of lactones with aryl and alkycyano compounds |
| 12/21/2005 | EP1606251A2 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 12/21/2005 | EP1606249A2 Compounds, a process for their preparation and their use as dyes and pigments |
| 12/21/2005 | EP1606248A2 Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 12/21/2005 | EP1606046A2 Production of 5-methyl-n-(methyl aryl)-2-pyrrolidone, 5-methyl-n-(methyl cycloalkyl)-2-pyrrolidone and 5- methyl-n-alkyl-2-pyrrolidone by reductive amination of leuvlinic acid esters with cyano compounds |
| 12/21/2005 | EP1605934A1 Production of 5-methyl-n-(methyl aryl)-2-pyrrolidone, 5-methyl-n-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone |
| 12/21/2005 | EP1605933A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5- methyl-n-cycloalkyl-2-pyrrolidone by reductive amination of levulinic acid with aryl amines |
| 12/21/2005 | EP1605756A2 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with aryl and alkyl amines |
| 12/21/2005 | EP1605755A2 Production of n-aryl-2-lactam and n-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds |